Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications.

Kanbayashi T, Shimohata T, Nakashima I, Yaguchi H, Yabe I, Nishizawa M, Shimizu T, Nishino S.

Arch Neurol. 2009 Dec;66(12):1563-6. doi: 10.1001/archneurol.2009.264.

PMID:
20008665
2.

The pathophysiologic basis of secondary narcolepsy and hypersomnia.

Kanbayashi T, Sagawa Y, Takemura F, Ito SU, Tsutsui K, Hishikawa Y, Nishino S.

Curr Neurol Neurosci Rep. 2011 Apr;11(2):235-41. doi: 10.1007/s11910-011-0178-y.

PMID:
21298561
3.
4.

Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.

Baba T, Nakashima I, Kanbayashi T, Konno M, Takahashi T, Fujihara K, Misu T, Takeda A, Shiga Y, Ogawa H, Itoyama Y.

J Neurol. 2009 Feb;256(2):287-8. doi: 10.1007/s00415-009-0139-4. No abstract available.

PMID:
19266146
5.

Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status.

Matsushita T, Isobe N, Piao H, Matsuoka T, Ishizu T, Doi H, Masaki K, Yoshiura T, Yamasaki R, Ohyagi Y, Kira J.

J Neurol Sci. 2010 Apr 15;291(1-2):37-43. doi: 10.1016/j.jns.2010.01.009.

PMID:
20122699
6.

Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.

Knudsen S, Jennum PJ, Korsholm K, Sheikh SP, Gammeltoft S, Frederiksen JL.

Mult Scler. 2008 Jul;14(6):734-8. doi: 10.1177/1352458508088939.

PMID:
18505777
7.

Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica.

Li W, Minohara M, Piao H, Matsushita T, Masaki K, Matsuoka T, Isobe N, Su JJ, Ohyagi Y, Kira J.

Mult Scler. 2009 Dec;15(12):1411-21. doi: 10.1177/1352458509348961.

PMID:
19965522
8.

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.

Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y.

Brain. 2007 May;130(Pt 5):1224-34.

9.

Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.

Martínez-Rodríguez JE, Lin L, Iranzo A, Genis D, Martí MJ, Santamaria J, Mignot E.

Sleep. 2003 May 1;26(3):287-90.

PMID:
12749547
10.

Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.

Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.

Arch Neurol. 2009 Sep;66(9):1164-7. doi: 10.1001/archneurol.2009.188.

PMID:
19752309
11.

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.

Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J.

Brain. 2007 May;130(Pt 5):1206-23.

12.

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.

Brain. 2007 May;130(Pt 5):1235-43.

13.

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.

Brain. 2007 May;130(Pt 5):1194-205.

14.

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S.

Arch Neurol. 2002 Oct;59(10):1553-62.

PMID:
12374492
15.

Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese.

Matsushita T, Isobe N, Matsuoka T, Shi N, Kawano Y, Wu XM, Yoshiura T, Nakao Y, Ishizu T, Kira JI.

Mult Scler. 2009 Jul;15(7):834-47. doi: 10.1177/1352458509104595.

PMID:
19465451
16.

Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.

Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Yoshiyama Y, Mitsuoka K, Ishibashi K, Sasaki S, Hattori T, Kuwabara S.

J Neuroimmunol. 2008 May 30;196(1-2):181-7. doi: 10.1016/j.jneuroim.2008.03.009.

PMID:
18462810
17.

A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.

Nozaki H, Shimohata T, Kanbayashi T, Sagawa Y, Katada S, Satoh M, Onodera O, Tanaka K, Nishizawa M.

Sleep Med. 2009 Feb;10(2):253-5. doi: 10.1016/j.sleep.2007.11.022.

PMID:
18226957
18.

Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights.

Ritchie C, Okuro M, Kanbayashi T, Nishino S.

Curr Neurol Neurosci Rep. 2010 May;10(3):180-9. doi: 10.1007/s11910-010-0100-z. Review.

PMID:
20425033
19.

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA.

Arch Neurol. 2006 Jul;63(7):964-8.

PMID:
16831965
20.

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.

Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F.

PLoS Med. 2007 Apr;4(4):e133.

Items per page

Supplemental Content

Support Center